Some people prefer an overlap approach, where they start retatrutide at a low dose while tapering off their previous medication
While traditionally considered first-line therapy, current American Diabetes Association guidance emphasizes a person-centered approach to initial medication selection based on comorbidities, treatment goals, and patient preferences
Theyre scientifically designed to act on appetite and blood sugar control, and research has shown their effectiveness in helping people lose significant weight and improve their blood sugar levels
As with similar receptor agonists, side effects continue to be evaluated through clinical trials
[12] [1] As an IMP, its storage and handling are governed by Good Clinical Practice (GCP) guidelines, EU/UK GMP Annex 13 (Investigational Medicinal Products), and the specific trial protocol not by a publicly available regulatory document